Sterile fill–finish line qualified

The new line performs aseptic filling of small-volume ampoules within a Grade A critical zone supported by a Grade B background, in line with EU/WHO GMP cleanroom expectations. Grade A protection is provided by unidirectional (laminar) airflow at 0.36–0.54 m/s, and the surrounding classified suite is served by dedicated HVAC and by Water-for-Injection and Purified Water utilities. Cleanroom classification and the associated ISO 14644 particle limits were confirmed during commissioning, with monitoring positions defined for both non-viable and viable counts.

“Qualification of the aseptic line confirms that ampoule filling can be performed reproducibly within the validated Grade A / B state Ergopharm requires for sterile production.”

Qualification followed the established IQ/OQ/PQ sequence and formed the process-qualification stage of Ergopharm's validation lifecycle. Performance was demonstrated through aseptic process simulations (media fills) covering routine interventions, alongside sterilisation and depyrogenation studies for direct product-contact components. Analytical release testing draws on the compendial framework the company applies to sterile products, including sterility (USP <71>), bacterial endotoxins by the LAL method (USP <85>) and particulate matter (USP <788>).

All batch records are maintained to ALCOA+ data-integrity principles, with release by the Qualified Person against the Batch Manufacturing Record and Certificate of Analysis. Deviation, out-of-specification and change-control procedures govern the line, and quality risk management is applied throughout in keeping with the ICH Q9 and Q10 framework that shapes Ergopharm's pharmaceutical quality system.

For distributors, the qualified line adds validated sterile ampoule capacity to Ergopharm's export register and underpins the consistency of supply required for prescription-only injectables. The company will now move to continued process verification, monitoring process performance and product quality across routine production so that ongoing output remains within the validated state established at qualification.